InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
$kytrader Free
04/18/19 4:30 PM
profile icon
Lazarus Grandfathered
04/16/19 11:38 AM
profile icon
XenaLives PremiumMember
03/28/19 9:45 PM
profile icon
chrispy2468 Free
03/28/19 10:12 AM
profile icon
blanka PremiumMember
03/27/19 12:19 PM
profile icon
Whatsupp Free
03/27/19 10:32 AM
profile icon
blanka PremiumMember
03/27/19 10:21 AM
profile icon
Whatsupp Free
03/27/19 10:19 AM
profile icon
blanka PremiumMember
03/27/19 10:14 AM
profile icon
Whatsupp Free
03/27/19 10:11 AM
profile icon
Whatsupp Free
03/27/19 9:51 AM
profile icon
PStockPickz Free
03/26/19 9:14 PM
profile icon
finishgreen Free
03/25/19 9:33 AM
profile icon
VERITAS77 Free
03/22/19 8:01 PM
profile icon
XenaLives PremiumMember
03/21/19 3:44 PM
profile icon
finishgreen Free
03/21/19 3:41 PM
profile icon
Cbdpotential Free
03/21/19 2:25 PM
profile icon
FALCON1 Free
03/21/19 1:05 PM
profile icon
FALCON1 Free
03/21/19 1:03 PM
profile icon
biotechnician Free
03/21/19 12:48 PM
profile icon
Cbdpotential Free
03/21/19 12:47 PM
profile icon
XenaLives PremiumMember
03/21/19 12:39 PM
profile icon
FALCON1 Free
03/21/19 12:25 PM
profile icon
XenaLives PremiumMember
03/21/19 12:11 PM
profile icon
Whosetosay Free
03/21/19 11:37 AM
profile icon
moe_the_gyp01 Free
03/21/19 11:12 AM
profile icon
biotechnician Free
03/21/19 11:06 AM
profile icon
XenaLives PremiumMember
03/21/19 10:10 AM
profile icon
Whosetosay Free
03/21/19 10:04 AM
profile icon
BostonSportsNut Free
03/21/19 9:59 AM
profile icon
XenaLives PremiumMember
03/21/19 9:00 AM
profile icon
Greenspam3 Free
03/21/19 8:54 AM
profile icon
Johnny_C Free
03/21/19 8:54 AM
profile icon
XenaLives PremiumMember
03/21/19 8:33 AM
profile icon
XenaLives PremiumMember
03/14/19 12:09 PM
profile icon
XenaLives PremiumMember
01/30/19 8:58 AM
profile icon
XenaLives PremiumMember
01/04/19 8:22 PM
profile icon
XenaLives PremiumMember
11/29/18 6:26 AM
profile icon
XenaLives PremiumMember
11/09/18 12:17 PM
profile icon
mauismart Free
10/28/18 10:48 AM
profile icon
biotechnician Free
10/26/18 10:15 AM
profile icon
McMagyar PremiumMember
10/25/18 10:42 PM

Biogen Inc (BIIB) RSS Feed

Followers
43
Posters
157
Posts (Today)
0
Posts (Total)
626
Created
11/17/07
Type
Free
Moderators

 http://www.idecpharm.com/

http://finance.yahoo.com/q/ks?s=BIIB

Biogen Idec Inc., a biotechnology company, develops, manufactures, and commercializes novel therapeutics in the areas of neurology, oncology, immunology, cardiopulmonary, and hemophilia in the United States and internationally. The company?s marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, low-grade or follicular, CD20-positive, and B-cell Non-Hodgkin?s Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe psoriasis. Its products under development consist of BG-12, a Phase III clinical trial product for the treatment of MS; Humanized Anti-CD20 MAb, a Phase III clinical trial product for the treatment of rheumatoid arthritis and lupus nephritis; Lixivaptan, a Phase III clinical drug for the treatment of Hyponatremia; Daclizumab, a Phase II monoclonal antibody that is being tested in relapsing MS; and Fampridine, an oral compound as a treatment to improve walking ability in people with MS. The company?s products under preclinical stage comprise BIIB014, Ocrelizumab, Neublastin, LINGO, and BART for neurology; Hsp90 Inhibitor, GA101, Anti-IGF-1R, Volociximab, Anti-CRIPTO, RAF Inhibitor, and Anti-Fn14 for oncology; Anti-TWEAK, Anti-CD40L Fab, and Anti-FcRn for immunology; and Long-acting rFactor VIII for hemophilia. It has collaboration agreements with Neurimmune SubOne AG; Cardiokine Biopharma LLC; UCB, S.A.; Swedish Orphan Biovitrum AB; Facet Biotech Corporation; Vernalis plc; and Schering AG. The company was founded in 1985 and is based in Cambridge, Massachusetts.

New Post